A review of systemic lupus erythematosus and current treatment options; Focus on bazedoxefine; Agents in late-stage development for major depressive disorder and generalized anxiety disorder
FDA Issues Complete Response Letter for Pz-Cel to Treat Epidermolysis Bullosa
April 22nd 2024Prademagene zamikeracel is a cell therapy designed to incorporate the functional collagen-producing COL7A1 gene into a patient’s own skin cells. The FDA is asking for additional information on manufacturing practices.